Patients with Type II Diabetes seeking blood sugar control currently have a wide range of treatment options. Among some of the newest types of medications available are Januvia and Janumet, two distinct medications that help patients achieve glycemic control. When seeking which treatment option is right for your diabetes, consider preexisting conditions and previous difficulty controlling your high blood sugar.
Januvia vs. Janumet
Januvia belongs to a class of diabetes medications called DDP-4 inhibitors that help patients with type II diabetes achieve blood sugar control when used alongside diet and exercise. The main active ingredient in Januvia, stagliptin, offers type II diabetes control in two distinct ways. When taken once daily, DDP-4 inhibitors work by increasing the insulin produced by the pancreas to stabilize elevated blood sugar levels, and by lowering the blood sugar released by the liver. This unique mechanism of action helps patient with type II diabetes achieve control of blood sugar levels, to prevent long term diabetes complications like nerve damage, kidney failure, and eye damage that can lead to blindness.
While Januvia offers blood sugar control, the maximum benefits of this treatment are dependent on a diet that is low in saturated fats and limiting sugar intake. In addition to diet, Januvia works best when patients follow a regular exercise routine to maintain lower body weight to prevent serious complications related to type II diabetes.
Janumet is similar to Januvia in that it contains the same active ingredient, stagliptin, to lower blood sugar levels. However, Janumet also includes metformin, an ingredient that reduces the amount of sugar the stomach absorbs to prevent blood sugar spikes. Another benefit of Janumet’s metformin ingredient is that it reduces amount of sugar that is released into the body from the liver stored in the liver, and it helps the body use sugar more effectively to prevent hypoglycemic episodes that can damage vital organs.
These treatment options should be considered carefully as they may not be suited for complicated cases of type II diabetes. Patients at risk for developing kidney disease should not take Januvia, as it may lead to irreversible damage. In patients with liver problems and congestive heart failure, Janumet is not recommended because it can cause lactic acidosis, a buildup of lactic acid that can lead to hospitalizations. Talking to your doctor to determine the best treatment option for your type II diabetes is recommended. To get free coupons and discounts on Januvia, Janumet or other diabetes medications, search our site for these drugs.